| Name | Title | Contact Details |
|---|
Alere is committed to delivering high performance diagnostics that meet growing global demand for accurate, easy-to-use and cost-effective tests. The Alere i molecular platform, for example, delivers lab-quality results for Influenza A&B in less than 15 minutes.
Transforming lives and communities with innovative and collaborative therapy, training and research. Company Overview: The Houston Galveston Institute (HGI) is a non-profit organization thatoffers a unique method of collaborative counseling and post-modern therapy to individuals, families and communities of all socioeconomic backgrounds. We base our approach on the belief That the client is the expert on his or her life and Circumstances. Our job, as therapists, is not to dictate treatment, but to shape the process using the values, desires and needs of our clients. Through this collaboration, clients find new solutions and the strength to endure Challenges and Overcome Obstacles.
Allegiance Life is a Missoula, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Highmark Blue Cross Blue Shield West Virginia is a Parkersburg, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.